What is H.C. Wainwright's price target for ANIP?

H.C. Wainwright's latest stated price target for ANI Pharmaceuticals Inc. (ANIP) is $84, from its action on Jul 10, 2025.

What is H.C. Wainwright's rating on ANIP?

H.C. Wainwright rates ANIP Buy, a bullish rating, as of Jul 10, 2025.

When did H.C. Wainwright last change its view on ANIP?

On Jul 10, 2025, H.C. Wainwright starts coverage at Buy, price target $84.

Analyst firms · H.C. Wainwright · ANIP

H.C. Wainwright ANIP price target and rating history

ANI Pharmaceuticals Inc. (ANIP) · Health Care

H.C. Wainwright rates ANI Pharmaceuticals Inc. (ANIP) Buy with a $84 price target, as of its latest action on Jul 10, 2025. It has published 3 rating actions on ANIP since September 2022, including 0 upgrades and 0 downgrades.

Current rating: Buy
Price target: $84
Median target, all firms: Too few
Actions on ANIP: 3

H.C. Wainwright price target on ANIP

H.C. Wainwright price target on ANIP, each point a stated target, September 2022 to July 2025.

Every H.C. Wainwright rating on ANIP

Jul 10, 2025
InitiateH.C. Wainwright starts coverage at Buy, price target $84
Aug 22, 2023
ReiterateH.C. Wainwright raises its price target to $73 from $60, keeps Buy
Sep 7, 2022
InitiateH.C. Wainwright starts coverage at Buy, price target $50

How other firms rate ANIP

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Oppenheimer	Perform		Sep 23, 2026
Leerink Partners	Outperform	$104	Sep 9, 2026
Canaccord Genuity	Hold	$91	Jul 17, 2026

Questions about H.C. Wainwright and ANIP

What is H.C. Wainwright's price target for ANIP?: H.C. Wainwright's latest stated price target for ANI Pharmaceuticals Inc. (ANIP) is $84, from its action on Jul 10, 2025.
What is H.C. Wainwright's rating on ANIP?: H.C. Wainwright rates ANIP Buy, a bullish rating, as of Jul 10, 2025.
When did H.C. Wainwright last change its view on ANIP?: On Jul 10, 2025, H.C. Wainwright starts coverage at Buy, price target $84.

All H.C. Wainwright ratings ANIP news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.